Government Medical Regulations Announcements
↖previous  1  | 2  next↗

DOH Announcement of the amendment of the article 106 of GCP Guideline ( 2010-07-19 )
DOH Announcement of the amendment of the article 106 of GCP Guideline on July 19, 2010
Attachment :
DOH announcement of the guideline for the test of teh electronic and IR thermometers. ( 2009-02-25 )
公告「臨床電子體溫計」、「紅外線耳溫槍」、「含粉手術用手套」等3項臨床前測試基準草案。
衛署藥字第0980302115號
Attachment :
DOH announcement of the re-evaluation of pergolide products (01/12/2009) ( 2009-01-15 )
公告含pergolide成分藥品之安全再評估結果相關事宜。
Attachment :
Regulation of the label of medical device-DOH 12/29/2008 ( 2009-01-07 )
有關醫療器材產品標籤及包裝之標示規定,詳如說明段,請貴會轉知所屬會員參照,請 查照。
Attachment :
DOH Announcement about the warning sentenct for products with Metformin-12/23/2008 ( 2009-01-07 )
公告含Metformin成分藥品仿單加刊警語注意事項相關事宜。
Attachment :
DOH Announcement about the "Taiwan Clinical Trial Information Network" and related issues ( 2006-07-07 )
DOH Announcement about the "Taiwan Clinical Trial Information Network" and related issues
Attachment :
DOH Announcement about the Regulations on Disclosing Drug Data ( 2006-02-27 )
DOH Announcement about the Regulations on Disclosing Drug Data
Attachment :
DOH Announcement about the implementation of amended Article 40-1 & 40-2 of Pharmaceutical Law ( 2005-10-28 )
DOH Announcement about the implementation of amended Article 40-1 & 40-2 of Pharmaceutical Law issued on October 28
Attachment :
DOH Announcement on the 3rd Validation Submission ( 2005-10-28 )
DOH Announcement on the 3rd Validation Submission issued on October 28 2005
Attachment :
Data Exclusivity Period of New Chemical Entity ( 2005-10-28 )
Announcement of the “Data Exclusivity Period of New Chemical Entity”
Attachment :
Stage III Validation Requirements ( 2005-10-28 )
Announcement regarding Stage III Validation Requirements
Attachment :
The affidavit form of disclosed patent number/ patent application number ( 2005-10-24 )
The affidavit form of disclosed patent number/ patent application number by DOH on October 24, 2005
Attachment :
Guidance on the Informed Consent for Pharmacogenomic Studies ( 2005-10-13 )
Guidance on the Informed Consent for Pharmacogenomic Studies by DOH on October 13, 2005
Attachment :
Stability Test Guideline ( 2005-05-03 )
Stability Test Guideline announced by DOH on April 01 2005
Attachment :
94.02.05 President’s Promulgation on Pharmaceutical Affairs Law Amendment ( 2005-02-15 )
Amendment Promulgation by President Hua- Zong- Yi- Yi- Tze No. 09400017691 issued on February 05th 2005.
To announce the Article 40-1; revise and augment the Article 40-2
Attachment :
Guideline for Toll Manufacturing and Contract Analysis ( 2004-10-31 )
Regulation on the Guideline for Toll Manufacturing and Contract Analysis announced by DOH on October, 2004.
Attachment :
Regulation on the Application of GMP Certificate ( 2004-12-01 )
Regulation on the Application of GMP Certificate announced by DOH on December, 2004.
Attachment :
Regulation on the Reporting of Adverse Drug Reactions (ADR) ( 2004-09-30 )
Regulation on the Reporting of Adverse Drug Reactions (ADR) announced by DOH on Auguest, 2004.
Attachment :
Regulation on the Surveillance of Drug Safety ( 2004-10-30 )
Regulation on the Surveillance of Drug Safety announced by DOH on September, 2004.
Attachment :
DOH announcement about the amendment of the Pharmaceutical affairs law ( 2004-04-30 )
The announcement of the amendment of the Pharmaceutical Affairs law.
Attachment :

previous  1  | 2  next↘

←HOME | ↑TOP